Company intelligence / Profile preview

Vibrent Health

Fairfax, Virginia, United Statesvibrenthealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vibrent Health’s digital health platforms are used by the NIH All of Us Research Program to collect diverse participant data at national scale (>400,000 participants), including genomics and real-world evidence. The company’s tools have enabled landmark studies in precision medicine and public health response to COVID‑19. No clinical trial results as the company does not develop drugs or devices.

Therapeutic areas: OtherMetabolic DisordersOncologyInfectious Diseases
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

National Institutes of Health (NIH) – All of Us Research Program participant technology partner since February 2017; awarded $75M initial funding plus additional contracts ($39M recompete award)Massey Cancer Center/VCU – partnered on a landmark cancer study

Beyond the preview

Go deeper on Vibrent Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrent Health.

Explore the full profile